Knowledge and Willingness to Accept Vaccine Against SARS-CoV-2 Among Undergraduate Medical Students in Delhi, India
- PMID: 35444813
- PMCID: PMC8987466
- DOI: 10.12865/CHSJ.47.04.01
Knowledge and Willingness to Accept Vaccine Against SARS-CoV-2 Among Undergraduate Medical Students in Delhi, India
Abstract
Vaccination against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the most desired solution to combat COVID-19. Understanding the willingness to accept vaccines is essential to make appropriate strategies for the vaccination programme's success. There was a lack of published literature in India among medical students. Hence, we conducted this online, cross-sectional study to assess the knowledge and willingness to accept COVID-19 vaccines among undergraduate medical students of a medical school in Delhi. A complete enumeration of all the undergraduate medical students was done. All the students were invited to participate in this online survey. The questionnaire through Google forms was shared through email and WhatsApp. The questionnaire contained questions on the socio-demographic details, questions related to the knowledge and perceptions about COVID-19 vaccines, willingness to accept the vaccine and vaccination status of the participant. Descriptive and multiple logistic regression analyses were carried out. Out of 320 students contacted, 298 consented to participate in the survey, and 274 participants (85%) completed the questionnaire. Three-fourths of the participants were male; the mean age of the study participants was 19.6 years. Only 70.4% were willing to accept the vaccine. Those who perceived COVID-19 vaccines as safe (AOR=3.946; 95% CI: 1.946 to 7.912); and effective (AOR=2.079; 95% CI: 1.054 to 4.101); and who has knowledge about the vaccines (AOR=2.206; 95% CI: 1.186 to 4.104) were more likely to accept the vaccine. There is a need for enhancing the knowledge on vaccines, and their safety and effectiveness to promote the vaccine acceptance.
Keywords: COVID-19; India; SARS-CoV-2; medical students; vaccine acceptance; vaccine hesitancy.
Copyright © 2014, Medical University Publishing House Craiova.
Conflict of interest statement
None to declare.
Similar articles
-
COVID-19 vaccine acceptance and its determinants: A cross-sectional study among the socioeconomically disadvantaged communities living in Delhi, India.Vaccine X. 2022 May 18;11:100171. doi: 10.1016/j.jvacx.2022.100171. eCollection 2022 Aug. Vaccine X. 2022. PMID: 35607603 Free PMC article.
-
COVID-19 vaccine acceptance, hesitancy, and associated factors among medical students in Sudan.PLoS One. 2022 Apr 7;17(4):e0266670. doi: 10.1371/journal.pone.0266670. eCollection 2022. PLoS One. 2022. PMID: 35390097 Free PMC article.
-
Community health workers willingness to participate in COVID-19 vaccine trials and intention to vaccinate: A cross-sectional survey in India.Clin Epidemiol Glob Health. 2022 Sep-Oct;17:101113. doi: 10.1016/j.cegh.2022.101113. Epub 2022 Jul 30. Clin Epidemiol Glob Health. 2022. PMID: 35935532 Free PMC article.
-
Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross-sectional survey.J Integr Med. 2022 Jan;20(1):34-44. doi: 10.1016/j.joim.2021.10.004. Epub 2021 Oct 26. J Integr Med. 2022. PMID: 34774463 Free PMC article. Review.
-
Trust is the common denominator for COVID-19 vaccine acceptance: A literature review.Vaccine X. 2022 Dec;12:100213. doi: 10.1016/j.jvacx.2022.100213. Epub 2022 Sep 29. Vaccine X. 2022. PMID: 36217424 Free PMC article. Review.
Cited by
-
Global Prevalence and Potential Influencing Factors of COVID-19 Vaccination Hesitancy: A Meta-Analysis.Vaccines (Basel). 2022 Aug 19;10(8):1356. doi: 10.3390/vaccines10081356. Vaccines (Basel). 2022. PMID: 36016242 Free PMC article. Review.
-
Novel COVID-19 vaccine hesitancy and acceptance, and associated factors, amongst medical students: a scoping review.Med Educ Online. 2023 Dec;28(1):2175620. doi: 10.1080/10872981.2023.2175620. Med Educ Online. 2023. PMID: 36788502 Free PMC article.
-
COVID-19 vaccination intention among nursing, medical, and dental students: A systematic review and meta-regression analysis.Hum Vaccin Immunother. 2023 Aug;19(2):2253600. doi: 10.1080/21645515.2023.2253600. Epub 2023 Sep 21. Hum Vaccin Immunother. 2023. PMID: 37732552 Free PMC article.
-
Correspondence on Knowledge and Willingness to Accept COVID-19 Vaccine.Curr Health Sci J. 2022 Apr-Jun;48(2):145. doi: 10.12865/CHSJ.48.02.01. Epub 2022 Jun 30. Curr Health Sci J. 2022. PMID: 36320875 Free PMC article. No abstract available.
-
Acceptability and perception of COVID-19 vaccines among foreign medical students in China: A cross-sectional study.Front Public Health. 2023 Mar 28;11:1112789. doi: 10.3389/fpubh.2023.1112789. eCollection 2023. Front Public Health. 2023. PMID: 37056651 Free PMC article.
References
-
- Draft landscape and tracker of COVID-19 candidate vaccines. Geneva: World Health Organization; 2021. Available from: https://www.who.int/publications/m/item/draft-landscape-of-covid-19-cand...[Accessed 19.07.2021]
-
- Bharat Biotech and ICMR Announce Interim Results from Phase 3 trials of COVAXIN®. Hyderabad: Bharat Biotech: 21 July 2021. Available from: https://www.bharatbiotech.com/images/press/covaxin-phase3-clinical-trial...[Accessed 21.01.2021]
-
- Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, Bibi S, Briner C, Cicconi P, Collins AM, Colin-Jones R, Cutland CL, Darton TC, Dheda K, Duncan CJA, Emary KRW, Ewer KJ, Fairlie L, Faust SN, Feng S, Ferreira DM, Finn A, Goodman AL, Green CM, Green CA, Heath PT, Hill C, Hill H, Hirsch I, Hodgson SHC, Izu A, Jackson S, Jenkin D, Joe CCD, Kerridge S, Koen A, Kwatra G, Lazarus R, Lawrie AM, Lelliott A, Libri V, Lillie PJ, Mallory R, Mendes AVA, Milan EP, Minassian AM, McGregor A, Morrison H, Mujadidi YF, Nana A, O'Reilly PJ, Padayachee SD, Pittella A, Plested E, Pollock KM, Ramasamy MN, Rhead S, Schwarzbold AV, Singh N, Smith A, Song R, Snape MD, Sprinz E, Sutherland RK, Tarrant R, Thomson EC, Torok ME, Toshner M, Turner DPJ, Vekemans J, Villafana TL, Watson MEE, Williams CJ, Douglas AD, Hill AVS, Lambe T, Gilbert SC, Pollard AJ, Oxford CVTG. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99–111. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous